Related Experiment Video
Updated: Sep 16, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Time trends incidence of celiac disease in a Spanish population
Julia María Cabo Del Riego1,2, María Jesús Núñez-Iglesias2,3, Andrés Blanco Hortas4
1Clinical Analysis Laboratory, Department of Immunology, Lucus Augusti University Hospital, Lugo, Spain.
Background/Objective:
Very few studies on celiac disease (CD) incidence across all age groups have been carried out so far, particularly in Spain. We evaluate the time trend incidence of CD of children, adults and elderly.
Methods:
Prospective study. Using an integrative primary and tertiary care setting approach with a standardized algorithm we identify all new cases of CD from January 1, 2012, to December 31, 2019, in a well-defined area of Galicia county, Spain. The crude incidence rate of CD was calculated as new cases per 100.000 person/year. Incidence rates were stablished by age categories 0-4, 5-19, 20-44, 45-64, 65-84, ≥ 85 and periods of 1-year intervals.
Results:
Between 2012 and 2019, 19,564 patients with suspicion and risk of CD were tested. 294 new cases of CD were diagnosed. Increasing CD incidence was observed from 13.11 per 100.000 person/year in 2012 to 20.92 per 100.000 100.000 person/year in 2019 (95% CI = 6.8-15.5). The temporal trend in incidence rates diverges between different age groups; showing a high incidence with stable pattern in children and young people whereas exhibiting an increasing incidence in adult/elderly, so that the incidence almost triple from 2012 to 2019. Classic CD symptoms decreasing frequency among incident cases was observed over time.
Conclusions:
A standardized algorithm for CD diagnosis with first-line serology testing followed by biopsy, if needed according to guidelines, confirmed the CD increasing incidence over 8 years period.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Assessment of the Gastrointestinal System II: Health Perception Pattern
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Longitudinal Research
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

